Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Pulmonary hypertension
Age: Adult: greater than 12 years
Dose: Oral – 62.5 mg
Frequency: twice daily
Note: Initial and maintenance dose
Indication: Pulmonary hypertension
Age: Adult: greater than 12 years
Condition: Initial treatment
Dose: Oral – 62.5 mg
Frequency: twice daily
Duration: 4 weeks

Child Dose

Clinical InformationAdministration Information
Indication: Pulmonary Arterial Hypertension
Age: less than 3 years
Dose: Not applicable – Not applicable
Note: Safety and efficacy not established
Indication: Pulmonary Arterial Hypertension
Age: 3 to greater than 12 years
Dose: Maintain dose – 16 mg
Frequency: twice daily

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment or dialysis
Dose: Not specified – Not specified
Note: No dosage adjustment needed in renal impairment or dialysis patients.
Administration
  • Take with or without food
  • Take at same times
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP3A4 inhibitors, CYP2C9 inhibitors
Increased bosentan levels
Rifampicin
Initially increases but subsequently decreases concentration

Disease Interaction

Disease NameRisk Factors
WHO Class II Symptoms
Risk of hepatotoxicity

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C. Store in a cool and dry place, protected from light. Keep out of children’s reach.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.